Physician profile
Jasmin Jo
NPI 1831487172
$1,019.61
in general payments reported to CMS, 2019-2025
24 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $228 · 2021: $99.95 · 2022: $23.18 · 2023: $79.71 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $246.81 | 2019-2023 | Pemazyre, Jakafi |
| Novocure INC. | $128.00 | 2025 | Optune Gio |
| Pfizer INC. | $67.55 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $58.69 | 2019-2023 | Keytruda, Lynparza |
| Amgen INC. | $48.30 | 2019-2020 | |
| Genentech USA, INC. | $47.58 | 2019-2020 | |
| Tesaro, INC. | $45.08 | 2019 | |
| Cala Health, INC. | $42.74 | 2023 | Cala Trio |
| E.R. Squibb & Sons, L.L.C. | $37.15 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.00 | 2019 | |
| Lilly USA, LLC | $33.08 | 2019-2025 | Verzenio, Jaypirca |
| Jazz Pharmaceuticals INC. | $30.62 | 2019-2020 | |
| Glaxosmithkline, LLC. | $29.86 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Genzyme Corporation | $23.52 | 2019 | |
| Daiichi Sankyo INC. | $19.05 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $18.92 | 2019 | |
| Astellas Pharma US INC | $15.87 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.02 | 2019 | |
| Seagen INC. | $13.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.50 | 2019 | |
| Shire North American Group INC | $13.37 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.35 | 2020 | |
| Kyowa Kirin, INC. | $11.90 | 2019 | |
| Secura Bio, INC. | $9.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmin Jo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.